Table 2.
Count and lifetime prevalence of disorders, by sex
| Male | Female | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Number of lifetime cases at time of interview |
Number of people in the sample in which the disorder was assessed |
Lifetime prevalence | Number of lifetime cases at time of interview |
Number of people in the sample in which the disorder was assessed |
Lifetime prevalence | Test statistics | |||
| Type of mental disorder | N1 | N2 | % | (95% CI) | N1 | N2 | % | (95% CI) | χ2 (p-value) |
| I. Anxiety disorders | |||||||||
| Panic disorder and/or agoraphobia | 1309 | 67808 | 1·9 | (1·8-2·1) | 3303 | 83328 | 3·7 | (3·6-3·9) | 289·6 (<0·0001) |
| Generalized anxiety disorder | 1955 | 71023 | 2·7 | (2·6-2·9) | 4500 | 85308 | 5·0 | (4·8-5·1) | 396·8 (<0·0001) |
| Post-traumatic stress disorder | 1456 | 35446 | 2·7 | (2·5-2·9) | 3721 | 47223 | 5·4 | (5·2-5·7) | 279·8 (<0·0001) |
| Social phobia | 2254 | 65428 | 3·5 | (3·3-3·7) | 3770 | 80849 | 4·6 | (4·4-4·8) | 69·5 (<0·0001) |
| Specific phobia | 2825 | 56355 | 5·0 | (4·8-5·3) | 6954 | 68781 | 10·0 | (9·7-10·2) | 744·6 (<0·0001) |
| Any anxiety disorder | 6559 | 39060 | 11·3 | (10·9-11·7) | 13830 | 50741 | 18·8 | (18·3-19·2) | 669·8 (<0·0001) |
| II. Mood disorders | |||||||||
| Major depressive disorder | 5324 | 71023 | 7·5 | (7·2-7·7) | 12144 | 85308 | 13·6 | (13·3-13·9) | 1160·5 (<0·0001) |
| Bipolar disorder | 1398 | 57559 | 2·5 | (2·4-2·7) | 1593 | 68307 | 2·3 | (2·1-2·4) | 7·2 (0·0074) |
| Any mood disorder | 6674 | 71023 | 9·5 | (9·2-9·7) | 13675 | 85308 | 15·4 | (15·1-15·7) | 880·6 (<0·0001) |
| III. Substance use disorders | |||||||||
| Alcohol abuse disorder | 7629 | 52757 | 13·7 | (13·3-14·1) | 2602 | 67650 | 3·3 | (3·1-3·4) | 2226·0 (<0·0001) |
| Alcohol dependence | 2056 | 52757 | 3·5 | (3·3-3·7) | 840 | 67650 | 0·9 | (0·9-1·0) | 516·5 (<0·0001) |
| Drug abuse disorder | 2083 | 46180 | 4·1 | (3·9-4·3) | 1204 | 59642 | 1·7 | (1·6-1·8) | 337·4 (<0·0001) |
| Drug dependence | 711 | 46180 | 1·4 | (1·3-1·6) | 490 | 59642 | 0·6 | (0·6-0·7) | 89·9 (<0·0001) |
| Any substance use disorder | 7926 | 46939 | 15·6 | (15·2-16·1) | 3181 | 60943 | 4·5 | (4·2-4·7) | 1960·2 (<0·0001) |
| IV. Externalizing disorders | |||||||||
| Attention deficit/hyperactivity disorder | 571 | 19402 | 2·4 | (2·1-2·7) | 575 | 25116 | 1·5 | (1·3-1·7) | 26·1 (<0·0001) |
| Intermittent explosive disorder | 1326 | 40529 | 3·5 | (3·2-3·7) | 1267 | 49561 | 2·5 | (2·4-2·7) | 39·4 (<0·0001) |
| Any externalizing disorder | 1524 | 30526 | 4·3 | (3·9-4·6) | 1563 | 39231 | 3·1 | (2·9-3·3) | 43·0 (<0·0001) |
| V. Any mental disorder | 14662 | 36700 | 28·6 | (27·9-29·2) | 21485 | 48444 | 29·8 | (29·2-30·3) | 9·2 (0·0024) |
Abbreviations: N1, observed (i.e., unweighted) number of respondents classified as meeting criteria for the disorder; N2, observed (i.e., unweighted) number of respondents in the sample; %, the ratio of N1 to N2 in the weighted, not unweighted, data; 95% CI, 95% confidence interval of %; χ2, Wald test for significance of difference between male and female values of %; P, P value of χ2 test.